The growth stalled for Genentech, the world’s second-largest biotech in terms of annual sales, in the third quarter, an analyst said Monday.Jim Reddoch, the analyst who lowered his expectations Monday for the biotech’s sales and earnings, said that quarterly sales declined for Genentech’s major products.
